ARVN analyst estimates

Arvinas (ARVN) analyst ratings, the average price target and its range, and every firm's latest call.

ARVN analyst ratings and price targets

DateFirmCallTarget
Nov 4, 2026H.C. WainwrightArvinas Inc. (ARVN) PT Lowered to $13 at H.C. Wainwright$13.00
Aug 10, 2026Evercore ISIArvinas price target lowered to $14 from $19 at Evercore ISI$14.00
Aug 10, 2026Morgan StanleyArvinas price target lowered to $10 from $11 at Morgan Stanley$10.00
Aug 5, 2026WedbushArvinas price target raised to $12 from $11 at Wedbush$12.00
Aug 4, 2026Wells FargoWells downgrades Arvinas to Equal Weight, sees catalysts coming in 2027$11.00
May 13, 2026BarclaysArvinas price target raised to $20 from $18 at Barclays$20.00
May 13, 2026BTIGArvinas price target raised to $18 from $16 at BTIG$18.00
Mar 18, 2026Truist FinancialTruist Securities Reiterates Hold Rating on Arvinas Inc. (ARVN) amid positive Parkinson's data$10.00
Feb 24, 2026WedbushArvinas price target raised to $11 from $9 at Wedbush$11.00
Dec 17, 2025BarclaysArvinas price target raised to $18 from $16 at Barclays$18.00
Oct 30, 2025BTIGArvinas Inc. (ARVN) PT Raised to $14 at BTIG$14.00
Oct 15, 2025Goldman SachsArvinas downgraded to Sell from Neutral at Goldman Sachs$6.00
Oct 7, 2025Piper SandlerArvinas price target raised to $16 from $14 at Piper Sandler$16.00
Sep 18, 2025StephensArvinas price target lowered to $14 from $16 at Stephens$14.00
Sep 18, 2025BTIGArvinas price target lowered to $10 from $16 at BTIG$10.00

Updated 2026-11-18 05:48 UTC